Global Blood: Q1 Earnings Snapshot

May 4, 2022 GMT

SOUTH SAN FRANCISCO, Calif. (AP) _ Global Blood Therapeutics Inc. (GBT) on Wednesday reported a loss of $81.4 million in its first quarter.

The South San Francisco, California-based company said it had a loss of $1.26 per share.

The results exceeded Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for a loss of $1.29 per share.

The biopharmaceutical company posted revenue of $55.2 million in the period, which fell short of Street forecasts. Eleven analysts surveyed by Zacks expected $56.4 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on GBT at